Please wait while the formulary information is being retrieved.
NEO-POLYCIN (NEOMYCIN SULFATE/BACITRACIN/POLYMYXIN B)
- Superficial ocular infection
neomycin-bacitracin-polymyxn 3.5 mg-400 unit-10,000 unit/gram eye oint
- Apply a small amount into the conjunctival sac(s) in affected eye(s) by ophthalmic route every 4 hours
3.5 mg-400 unit-10,000 unit/g eye ointment
- Apply a small amount into the conjunctival sac(s) in affected eye(s) by ophthalmic route every 4 hours
Superficial ocular infection
- Apply a small amount in the conjunctival sacs in both eyes by ophthalmic route every 4 hours
- Apply a small amount in the conjunctival sacs in both eyes by ophthalmic route every 3 hours for 7 days
- Apply a small amount in the conjunctival sacs in both eyes by ophthalmic route every 3 hours for 10 days
- Apply a small amount in the conjunctival sacs in both eyes by ophthalmic route every 4 hours for 10 days
- Apply a small amount into the conjunctival sac in the right eye by ophthalmic route every 3 hours for 7 days
- Apply a small amount into the conjunctival sac in the right eye by ophthalmic route every 3 hours for 10 days
- Apply a small amount into the conjunctival sac in the right eye by ophthalmic route every 4 hours for 7 days
- Apply a small amount into the conjunctival sac in the right eye by ophthalmic route every 4 hours for 10 days
- Apply a small amount in the conjunctival sac in the left eye by ophthalmic route every 3 hours for 7 days
- Apply a small amount in the conjunctival sac in the left eye by ophthalmic route every 3 hours for 10 days
- Apply a small amount in the conjunctival sac in the left eye by ophthalmic route every 4 hours for 7 days
- Apply a small amount in the conjunctival sac in the left eye by ophthalmic route every 4 hours for 10 days
- Apply a small amount in the conjunctival sacs in both eyes by ophthalmic route every 3 hours
- Apply a small amount in the conjunctival sac in the left eye by ophthalmic route every 4 hours
- Apply a small amount into the conjunctival sac in the right eye by ophthalmic route every 4 hours
- Apply a small amount in the conjunctival sac in the left eye by ophthalmic route every 3 hours
- Apply a small amount into the conjunctival sac in the right eye by ophthalmic route every 3 hours
- Apply a small amount into the conjunctival sac(s) in affected eye(s) by ophthalmic route every 3 hours
- Apply a small amount into the conjunctival sac(s) in affected eye(s) by ophthalmic route every 4 hours
- Apply a small amount into the conjunctival sac(s) in affected eye(s) by ophthalmic route every 3 hours for 7 days
- Apply a small amount into the conjunctival sac(s) in affected eye(s) by ophthalmic route every 3 hours for 10 days
- Apply a small amount into the conjunctival sac(s) in affected eye(s) by ophthalmic route every 4 hours for 7 days
- Apply a small amount into the conjunctival sac(s) in affected eye(s) by ophthalmic route every 4 hours for 10 days
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Ocular injury
Severe
Moderate
- No disease contraindications
NEO-POLYCIN (NEOMYCIN SULFATE/BACITRACIN/POLYMYXIN B)
- Superficial ocular infection
- Contact dermatitis
- Ocular inflammation
- Ocular itching
- Ocular redness
- Skin rash
- None
More Frequent
Severe
Less Severe
- Ocular irritation
- Blurred vision
- Ocular irritation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Apnea
- Chest tightness
- Facial edema
- Hypotension
Less Severe
- Candidiasis
- Hyperhidrosis
- Ocular irritation
- Ocular itching
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Bacitracin (ophth,top)
- Severity Level:
2
- Additional Notes: Insufficient data available.
Neomycin (ophth)
- Severity Level:
C
- Additional Notes: No single ingredient data. fda category c in combination product.
Polymyxin B Sulfate (ophth,otic,top)
- Severity Level:
B
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Bacitracin (inj,top,ophth)
Insufficient data available.
Insufficient data available
None
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
Neomycin (topical, Ophth)
Insufficient data available.
Insufficient data available
None
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
Polymyxin B
Insufficient data available.
Insufficient data available
None
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Superficial ocular infection | |
H10.0 | Mucopurulent conjunctivitis |
H10.01 | Acute follicular conjunctivitis |
H10.011 | Acute follicular conjunctivitis, right eye |
H10.012 | Acute follicular conjunctivitis, left eye |
H10.013 | Acute follicular conjunctivitis, bilateral |
H10.019 | Acute follicular conjunctivitis, unspecified eye |
H10.02 | Other mucopurulent conjunctivitis |
H10.021 | Other mucopurulent conjunctivitis, right eye |
H10.022 | Other mucopurulent conjunctivitis, left eye |
H10.023 | Other mucopurulent conjunctivitis, bilateral |
H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
0-9 | A-Z |
---|---|
H10.0 | Mucopurulent conjunctivitis |
H10.01 | Acute follicular conjunctivitis |
H10.011 | Acute follicular conjunctivitis, right eye |
H10.012 | Acute follicular conjunctivitis, left eye |
H10.013 | Acute follicular conjunctivitis, bilateral |
H10.019 | Acute follicular conjunctivitis, unspecified eye |
H10.02 | Other mucopurulent conjunctivitis |
H10.021 | Other mucopurulent conjunctivitis, right eye |
H10.022 | Other mucopurulent conjunctivitis, left eye |
H10.023 | Other mucopurulent conjunctivitis, bilateral |
H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
Formulary Reference Tool